The pet health business is big business. And one of its biggest players just got bigger. Greenfield, Indiana-based animal health company Elanco, formerly a division of Eli Lilly, has bought the animal health division of German conglomerate Bayer AG for $7.6 billion, making Elanco the second-largest player in the lucrative field with 13% market share, according to The Wall Street Journal. 

Elanco was represented by Paul, Weiss, Rifkind, Wharton & Garrison and Frankfurt, Germany-based Hengeler Mueller.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]